VOMS stands for Vestibular/Ocular Motor Screening, a quick clinical test used to detect concussions by checking how well your eyes and balance system work together. It evaluates five specific areas of function that are commonly disrupted after a head injury, making it one of the more practical tools clinicians use to identify concussion-related problems that standard neurological exams can miss.
What VOMS Measures
The screening targets five domains that rely on the connection between your brain, your eyes, and your inner ear balance system. When you sustain a concussion, these pathways are among the first to malfunction, even when everything else looks normal. The five areas tested are:
- Smooth pursuits: Your ability to track a slowly moving object with your eyes. The clinician moves a fingertip back and forth about three feet in front of you, and you follow it without moving your head.
- Rapid eye movements (saccades): How quickly and accurately your eyes jump between two fixed points. You’re asked to snap your gaze back and forth between two targets held about three feet apart, ten times in a row, both horizontally and vertically.
- Near point of convergence: How close an object can get to your nose before your eyes can no longer focus on it as a single image. You slowly bring a small target toward your face and stop when you see double. The clinician measures the distance in centimeters.
- Vestibular-ocular reflex (VOR): Whether your eyes can stay locked on a target while your head moves. You focus on a fixed point and rotate your head side to side, then up and down, in time with a metronome beat.
- Visual motion sensitivity: How your brain handles visual conflict during body movement. You stand, focus on your outstretched thumb, and rotate your head and trunk together from side to side while keeping your eyes fixed.
How the Test Is Scored
After each component, you rate three symptoms on a scale of 0 to 10: headache, dizziness, nausea, and a sense of mental fogginess. The clinician compares your post-test symptom ratings to your baseline (pre-test) ratings to see whether any individual test provoked symptoms. A total symptom score of 4 or higher across the screening is considered the threshold that best identifies a concussion. For the near point of convergence test specifically, a distance of 5 centimeters or greater from the nose raises the probability of concussion.
These aren’t pass-or-fail numbers in isolation. Clinicians look at the overall pattern: which tests triggered symptoms, how far above baseline the scores climbed, and whether the near point of convergence measurement is abnormal. A person who scores normally on four domains but spikes on VOR testing, for instance, gives the clinician useful information about which brain pathways were affected.
What It Takes to Administer
VOMS requires minimal equipment: a metronome (or a metronome app), a small visual target like a pen tip, and a ruler or tape measure for the convergence test. The entire screening takes roughly five to ten minutes. No imaging, no blood draw, no special technology. That simplicity is part of what makes it valuable in athletic training rooms, sideline evaluations, and primary care offices where quick, reliable concussion detection matters.
Where VOMS Fits in Concussion Evaluation
VOMS was originally validated for people aged 9 to 40, which covers most competitive athletes. It fills a gap that other concussion tools leave open. Standard assessments like the SCAT (Sport Concussion Assessment Tool) rely heavily on memory, concentration, and balance testing. VOMS specifically targets the vestibular and visual systems, which are involved in a large percentage of concussions but aren’t thoroughly evaluated by those other tools.
The 2022 Amsterdam International Consensus Statement on Concussion in Sport, the most authoritative guideline in the field, included a modified version of VOMS in its recommended evaluation protocol (the SCOAT6). The original full version didn’t reach the 80% agreement threshold for inclusion in the SCAT6 sideline tool, but the modified version was endorsed for use in the more comprehensive office-based evaluation that follows an initial sideline assessment.
VOMS for Children Under 10
Young children can’t reliably use the 0-to-10 rating scale that the standard VOMS requires. Kids under 10 tend to overreport symptoms, leading to higher false-positive rates compared to adolescents and adults. To address this, researchers developed the VOMS-C (VOMS-Child) for children aged 5 to 9. It uses a simple yes-or-no response format instead of the numerical scale and drops “fogginess” from the symptom list, since younger children often don’t understand the concept.
In testing, concussed children reported symptom provocation on 13% to 30% of VOMS-C items, while healthy controls reported provocation on 3% to 20% of items. The overlap between those ranges reflects the challenge of concussion screening in young children, where normal developmental variation and difficulty following instructions can muddy the results. Even so, the adapted version gives clinicians a structured way to screen a population that was previously difficult to assess with standardized tools.
What an Abnormal VOMS Result Means for You
An abnormal VOMS result doesn’t diagnose a concussion on its own. No single test does. But it tells your clinician that the vestibular-visual pathways in your brain aren’t functioning normally, which is strong evidence of concussion when combined with a recent head impact and other symptoms. It also points toward the type of rehabilitation you’re likely to need. Someone whose symptoms spike during the VOR test, for example, typically benefits from vestibular therapy that retrains the brain’s ability to stabilize vision during head movement. Someone with an abnormal near point of convergence may be referred for vision therapy focused on eye coordination.
VOMS results also serve as a recovery benchmark. Clinicians often repeat the screening at follow-up visits to track whether your vestibular and visual function is returning to normal. When your scores drop back to baseline and the tests no longer provoke symptoms, it’s one piece of evidence supporting a return to activity.